Filing metadata

Accession number
0000921895-22-001599
Form type
Form 4
Filer
Oruka Therapeutics, Inc.
CIK
CIK 907654
Filed
May 11, 2022
Reporting period
May 10, 2022
Description
Insider transaction

Explore SEC Filings Hub